BJDX vs VLTO · $5.0M cap vs P/E 29, rev $5.50B
Bluejay Diagnostics Inc (BJDX) versus Veralto Corporation (VLTO) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Veralto Corporation (VLTO) is a pollution & treatment controls company listed on US.
BJDX does not have a complete income-statement cache yet.
Latest reported VLTO revenue for 2025-12-31 was $5.50B. Net income was $940.0M. Revenue was up 6.0% from 2024-12-31 to 2025-12-31. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
BJDX currently screens at market cap $5.0M. VLTO currently screens at market cap $25.26B and trailing P/E 29.1.
Not investment advice. Open the BJDX and VLTO stock pages for the full models.
Not investment advice.